Demographics (2)
- SEX - Gender of participant (phv00278233.v3.p1)
- SEX - Sex (phv00527822.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject (phv00527823.v1.p1)
- AGE_ONSET - Disease onset age (phv00278235.v3.p1)
Race and Ethnicity (1)
- RACE - Race of participant (phv00278234.v3.p1)
Other (20)
- ANALYTE_TYPE - Analyte type (phv00278239.v4.p1)
- BODY_SITE - Body site where sample was collected (phv00278238.v3.p1)
- CONSENT - Consent group as determined by DAC (phv00278227.v3.p1)
- EBV_GENOME_TYPE - Viral genome type in tumor (phv00278245.v3.p1)
- EBV_LATENT - Names of RNA seq samples that have the latent EBV phenotype (phv00532543.v1.p1)
- EBV_LYTIC - Names of RNA seq samples that have the lytic EBV phenotype (phv00532542.v1.p1)
- EBV_STATUS - Viral presence in tumor (phv00278244.v3.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00278241.v3.p1)
- IN_HOSPITAL_SURVIVAL - Survival status in hospital (phv00278236.v3.p1)
- IS_TUMOR - Tumor status (phv00278240.v3.p1)
- NK_CELL_SUBTYPE - NK cell subtype (phv00426553.v2.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00278243.v3.p1)
- SAMPLE_ID - De-identified sample ID (phv00278237.v3.p1)
- SAMPLE_ID - Sample ID (phv00278230.v3.p1)
- SAMPLE_TYPE - Sample type (phv00426552.v3.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00278246.v4.p1)
- SUBJECT_ID - De-identified subject ID (phv00278232.v3.p1)
- SUBJECT_ID - Subject ID (phv00278226.v3.p1)
- SUBJECT_ID - Subject ID (phv00278229.v3.p1)
- TUMOR_SUBTYPE - Tumor subtype (phv00278242.v3.p1)